{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:19:32Z","timestamp":1783059572494,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["2E33742"],"award-info":[{"award-number":["2E33742"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbrc.2026.153785","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:53:08Z","timestamp":1777477988000},"page":"153785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells"],"prefix":"10.1016","volume":"821","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4663-6310","authenticated-orcid":false,"given":"Yeonseo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baknoon","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2647-7046","authenticated-orcid":false,"given":"Yeojin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Hwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-7520","authenticated-orcid":false,"given":"Hyunbeom","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153785_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010024","article-title":"Metabolic hallmarks of hepatic stellate cells in liver fibrosis","volume":"9","author":"Khomich","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153785_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153785_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00535-008-2180-y","article-title":"Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies","volume":"43","author":"Li","year":"2008","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.153785_bib4","first-page":"344","article-title":"Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology","volume":"3","author":"Weiskirchen","year":"2014","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.bbrc.2026.153785_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.0106-9543.2002.01674.x","article-title":"The correlation between portal myofibroblasts and development of intrahepatic bile ducts and arterial branches in human liver","volume":"22","author":"Libbrecht","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.bbrc.2026.153785_bib6","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/jgh.1998.13.s1.33","article-title":"Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis","volume":"13","author":"Arthur","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153785_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fphys.2012.00053","article-title":"Differential regulation of TGF-beta\/Smad signaling in hepatic stellate cells between acute and chronic liver injuries","volume":"3","author":"Yoshida","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2026.153785_bib8","article-title":"Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153785_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbalip.2008.11.001","article-title":"Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage","volume":"1791","author":"Blaner","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.153785_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells7090137","article-title":"Retinoids issued from hepatic stellate cell lipid droplet loss as potential signaling molecules orchestrating a multicellular liver injury response","volume":"7","author":"Bobowski-Gerard","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153785_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034945","article-title":"Replacement of retinyl esters by polyunsaturated triacylglycerol species in lipid droplets of hepatic stellate cells during activation","volume":"7","author":"Testerink","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153785_bib12","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.M410078200","article-title":"Adipogenic transcriptional regulation of hepatic stellate cells","volume":"280","author":"She","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2026.153785_bib13","article-title":"PPAR gamma and hepatic stellate cells","volume":"3","author":"Hazra","year":"2004","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153785_bib14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2026.153785_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbalip.2019.02.004","article-title":"Hepatic stellate cell activation: a source for bioactive lipids","volume":"1864","author":"Shmarakov","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbrc.2026.153785_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11010-020-03717-7","article-title":"Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism","volume":"468","author":"Silva","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.153785_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103042","article-title":"Lipidomic profiling of rat hepatic stellate cells during activation reveals a two-stage process accompanied by increased levels of lysosomal lipids","volume":"299","author":"Molenaar","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153785_bib18","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1038\/s41598-018-27686-6","article-title":"In vitro inhibition of hepatic stellate cell activation by the autophagy-related lipid droplet protein ATG2A","volume":"8","author":"Hong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153785_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2010.02.027","article-title":"New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis","volume":"53","author":"Wang","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153785_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/CAD.0000000000000316","article-title":"Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways","volume":"27","author":"Hao","year":"2016","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.bbrc.2026.153785_bib21","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1038\/s41598-021-82381-3","article-title":"Cytoplasmic vacuolation with endoplasmic reticulum stress directs sorafenib induced non-apoptotic cell death in hepatic stellate cells","volume":"11","author":"Sharma","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153785_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1alpha\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrc.2026.153785_bib23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.cmet.2020.04.011","article-title":"Low-dose sorafenib acts as a mitochondrial uncoupler and ameliorates nonalcoholic steatohepatitis","volume":"31","author":"Jian","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2026.153785_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149724","article-title":"Metabolomics and miRNA profiling reveals feature of gallbladder cancer-derived biliary extracellular vesicles","volume":"705","author":"Kong","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153785_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2026.153785_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s43152-021-00030-3","article-title":"Extracellular matrix remodeling in chronic liver disease","volume":"2","author":"Ortiz","year":"2021","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"10.1016\/j.bbrc.2026.153785_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153785_bib28","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","article-title":"Transforming growth factor-beta (TGF-beta)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation","volume":"288","author":"Liu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153785_bib29","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153785_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fbioe.2019.00166","article-title":"Collagen-based tissue engineering strategies for vascular medicine","volume":"7","author":"Copes","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153785_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169068","article-title":"Contrasting local and macroscopic effects of collagen hydroxylation","volume":"22","author":"Varma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153785_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-4-21","article-title":"Plasma and cellular fibronectin: distinct and independent functions during tissue repair","volume":"4","author":"To","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bbrc.2026.153785_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092443","article-title":"Fibronectin: molecular structure, fibrillar structure and mechanochemical signaling","volume":"10","author":"Dalton","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153785_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009712","article-title":"The thrombospondins","volume":"3","author":"Adams","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrc.2026.153785_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1369\/0022155419851103","article-title":"Thrombospondin 1 and its diverse roles as a regulator of extracellular matrix in fibrotic disease","volume":"67","author":"Murphy-Ullrich","year":"2019","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbrc.2026.153785_bib36","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153785_bib37","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.22890","article-title":"Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation","volume":"49","author":"Hong","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2026.153785_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151765","article-title":"Impact of a CXCL12\/CXCR4 antagonist in Bleomycin (BLM) induced pulmonary fibrosis and carbon tetrachloride (CCl4) induced hepatic fibrosis in mice","volume":"11","author":"Chow","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153785_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153785_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrc.2026.153785_bib41","article-title":"TGF-beta inhibitors: the future for prevention and treatment of liver fibrosis?","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153785_bib42","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1091\/mbc.e05-02-0149","article-title":"Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization","volume":"16","author":"Uemura","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2026.153785_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13435","volume":"56","author":"Tang","year":"2023","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrc.2026.153785_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0269-2020","article-title":"The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis","volume":"29","author":"Plate","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bbrc.2026.153785_bib45","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153785_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.153785_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13238-017-0409-3","article-title":"mTORC1 signaling in hepatic lipid metabolism","volume":"9","author":"Han","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbrc.2026.153785_bib48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","article-title":"Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c","volume":"15","author":"Hagiwara","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2026.153785_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.873971","article-title":"Layered double hydroxides-loaded sorafenib inhibit hepatic stellate cells proliferation and activation in vitro and reduce fibrosis in vivo","volume":"10","author":"Peng","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.153785_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092307","article-title":"A comprehensive review on collagen type I development of biomaterials for tissue engineering: from biosynthesis to bioscaffold","volume":"10","author":"Amirrah","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2026.153785_bib51","article-title":"Collagen in wound healing","volume":"8","author":"Mathew-Steiner","year":"2021","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.bbrc.2026.153785_bib52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cyto.2017.12.022","article-title":"Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3","volume":"109","author":"Murphy","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.bbrc.2026.153785_bib53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/cells13121027","article-title":"Crosstalk between CXCL12\/CXCR4\/ACKR3 and the STAT3 pathway","volume":"13","author":"Ma","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153785_bib54","doi-asserted-by":"crossref","first-page":"G203","DOI":"10.1152\/ajpgi.00193.2016","article-title":"Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases","volume":"311","author":"Liepelt","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrc.2026.153785_bib55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7150\/thno.21168","article-title":"Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development","volume":"8","author":"Sung","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2026.153785_bib56","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153785_bib57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bbrc.2017.10.110","article-title":"Dihydroceramide is a key metabolite that regulates autophagy and promotes fibrosis in hepatic steatosis model","volume":"494","author":"Lee","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.153785_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.62","article-title":"Cytochrome c oxidase deficiency accelerates mitochondrial apoptosis by activating ceramide synthase 6","volume":"6","author":"Schull","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.153785_bib59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2012.04.008","article-title":"A shift in sphingolipid composition from C24 to C16 increases susceptibility to apoptosis in HeLa cells","volume":"1821","author":"Sassa","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.153785_bib60","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.bbamcr.2014.12.039","article-title":"Ceramide induced mitophagy and tumor suppression","volume":"1853","author":"Dany","year":"2015","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26005498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:38:44Z","timestamp":1783057124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26005498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"alternative-id":["S0006291X26005498"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153785","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low concentrations of sorafenib increase dihydrosphingomyelin during antifibrotic processes in human hepatic stellate cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153785"}}